Articles

China is a key player in global clinical trials, yet its intricate regulatory environment and logistical challenges demand meticulous supply chain management. Catalent provides tailored services such as Free Trade Zones, temperature-controlled shipping, and local comparator sourcing to support sponsors in executing trials effectively and in compliance with regulations.

Optimizing Clinical Trials in China with Strategic Solutions for Supply Chain Challenges

The landscape of cell and gene therapy is rapidly evolving, with increasing approvals for diverse indications. Preserving the integrity and efficacy of cell and gene therapy products is critical. Vial adapters facilitate the transfer of drug product from a vial by securing an efficient connection between the vial and the administration device. Learn more about how sterility and accurate dosing are maintained while preserving stability.

Vial Adapter Considerations for Cell and Gene Therapy Applications

The Roadmap to Asset Performance Management in Life Science

Unlock the Future of Enterprise Asset Management with Agentic AI

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:



Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

What it takes to bring complex inhaled therapies to market—faster and smarter.

Rethinking Inhalation Drug Development

Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

All Whitepapers